DrugPatentWatch Database Preview
Litigation Details for Anesta AG v. Mylan Pharmaceuticals Inc. (D. Del. 2008)
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
Anesta AG v. Mylan Pharmaceuticals Inc. (D. Del. 2008)
| Docket | Start Trial | Date Filed | 2008-11-25 |
| Court | District Court, D. Delaware | Date Terminated | 2014-09-24 |
| Cause | 35:271 Patent Infringement | Assigned To | Sue Lewis Robinson |
| Jury Demand | Defendant | Referred To | |
| Parties | ANESTA AG; APTALIS PHARMATECH, INC.; BARR LABORATORIES INC.; BARR PHARMACEUTICALS INC.; CEPHALON INC.; EURAND INC.; IVAX INTERNATIONAL GMBH; MYLAN INC.; MYLAN PHARMACEUTICALS INC.; PAR PHARMACEUTICAL INC.; TEVA PHARMACEUTICAL INDUSTRIES LTD.; TEVA PHARMACEUTICALS USA, INC. | ||
| Patents | 6,344,215; 7,387,793; 7,544,372 | ||
| Attorneys | Adrienne G. Johnson; Bindu Ann George Palapura; Brian E. Farnan; Brian H. Pandya; Dana Kathryn Severance; David Ellis Moore; Douglas Edward McCann; Edward G. Poplawski; Erich William Struble; Geoffrey D. Biegler; George C. Lombardi; Ian Robert Liston; Jaclyn Michele Mason; James H. Wallace , Jr.; Jennifer Lynne Hall; John C. Phillips , Jr.; John R. Lane; Jonathan E. Singer; Joseph Benedict Cicero; Julia M. Johnson; Lindsay M. Beyer; Lynn M. Ulrich; Mark A. Pacella; Matthew J. Dowd; Maureen L. Rurka; Megan C. Haney; Michael S. Sommer; Olivia M. Kim; Paul Damon Brown; Richard L. Horwitz; Richard S. Sanders; Robert J. Scheffel; Robert M. Oakes; Sheryl S. Bassin; Susan Morrison Coletti; Tryn T. Stimart; William B. Chandler , III; William J. Marsden , Jr. | ||
| Firms | Phillips, Goldman & Spence, P.A.; Wilson Sonsini Goodrich & Rosati PC; Womble Carlyle Sandridge & Rice, LLP | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Anesta AG v. Mylan Pharmaceuticals Inc.
The small molecule drugs covered by the patents cited in this case are Start Trial and Start Trial .
Details for Anesta AG v. Mylan Pharmaceuticals Inc. (D. Del. 2008)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2010-03-08 | 146 | that the failure to disclose U.S. Patent No. 6,344,215 (“the ‘215 patent) to the PTO constitutes inequitable… files of the two inventors of the patent-in-suit (“the ‘793 patent”) on the issue of inequitable conduct… prosecution of the ‘793 patent).l During the prosecution of the ‘793 patent, the inventors and their…conduct. The ‘21 5 patent identifies as an inventor one of the two inventors of the ‘793 patent and, like the…the ‘793 patent, was assigned to Eurand. The ‘215 patent discloses a formulation with methylphenidate | External link to document | |
| 2011-05-18 | 231 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,387,793 B2; 7,544,372 B2. (… 24 September 2014 1:08-cv-00889-SLR Patent Defendant District Court, D. | External link to document | |
| 2011-05-12 | 246 | European Patent Application No. 92109699.6 to Urban ("Urban"), and US Patent No. 6,344,215 ("… U.S. Patent Nos. 7,387,793 (lithe '793 patent") and 7,544,372 (lithe '372 patent")… for its use. The '372 patent is a divisional patent of the 793 patent, and shares both its specification…of the patents-in-suit, is also a named inventor on the '215 patent and the '215 patent forms …#39;215 patent was material to the prosecution of the '793 patent because the '215 patent is directed | External link to document | |
| 2008-11-26 | 3 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,387,793 B2; (dzs, ) (Entered… 24 September 2014 1:08-cv-00889-SLR Patent Defendant District Court, D. | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
